Author

THOMAS D BOYER

Observed names: Boyer, TD, Boyer, Thomas D, Boyer, Thomas D., T BOYER, T D Boyer, T. Boyer, T. D. Boyer, T.D. Boyer, THOMAS D. BOYER, Thomas B. Boyer, Thomas Boyer, Thomas D Boyer, Thomas D. BOYER, Thomas D. Boyer, Thomas David Boyer, Thomas D. BOYER, Thomas D. Boyer

Observed institutions: Inova Health System, University of Southern California, San Francisco VA Medical Center, Cleveland Clinic, United States Department of Veterans Affairs, Children's Hospital Los Angeles, University of Arizona, Johns Hopkins University, Emory University, University of California, San Francisco, Indiana University Hospital, Southampton General Hospital, Royal Hallamshire Hospital, University of California System, National Institute of Diabetes and Digestive and Kidney Diseases, Nagoya University Hospital, Plastic Surgery Hospital, Quest Clinical Research (United States), University of California San Francisco Medical Center, Banner - University Medical Center Tucson, Altasciences Clinical Research Vince & Associates, Johns Hopkins Hospital, Atlanta VA Medical Center, University of Southampton, Indiana University Indianapolis, Indiana University School of Medicine, Nagoya University, Medical Research Council

ORCID: 0000-0001-8133-5491

Observed ORCID: 0000-0001-8133-5491

OpenAlex ID: A5071325908

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

2015 · Paolo Angeli, Pere Ginès, et al. · Journal of Hepatology · 864

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

2008 · Arun J. Sanyal, Thomas Boyer, et al. · Gastroenterology · 664

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

2015 · Paolo Angeli, Pere Gines, et al. · Gut · 582

the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009

2009 · Thomas D. Boyer, Ziv J. Haskal · Hepatology · 549

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

2018 · Salvatore Piano, Virendra Singh, et al. · Gastroenterology · 521

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†

2005 · Thomas D. Boyer, Ziv J. Haskal · Hepatology · 445

Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C

2001 · Rajender K. Reddy, Teresa L. Wright, et al. · Hepatology · 360

Human Glutathione S-Transferases

1998 · Richard Whalen, Thomas Boyer · Seminars in Liver Disease · 350

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

2016 · Thomas D. Boyer, Arun J. Sanyal, et al. · Gastroenterology · 309

Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.

1979 · T D Boyer, P Zia, et al. · PubMed · 275

Predictors of Large Esophageal Varices in Patients With Cirrhosis

1999 · Naga Chalasani, Thomas F Imperiale, et al. · The American Journal of Gastroenterology · 268

Distal Splenorenal Shunt Versus Transjugular Intrahepatic Portal Systematic Shunt for Variceal Bleeding: A Randomized Trial

2006 · J. Michael Henderson, Thomas D. Boyer, et al. · Gastroenterology · 254

Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease

1979 · Thomas D. Boyer, Priscilla Zia, et al. · Gastroenterology · 252

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics

2010 · Thomas D. Boyer, Arun J. Sanyal, et al. · Journal of Hepatology · 249

Direct Transhepatic Measurement of Portal Vein Pressure Using a Thin Needle

1977 · Thomas D. Boyer, David R. Triger, et al. · Gastroenterology · 245

Special article the glutathione S-transferases: An update

1989 · Thomas D. Boyer · Hepatology · 221

Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting

2000 · Naga Chalasani, W.Scott Clark, et al. · Gastroenterology · 209

Acetaminophen-Induced Hepatic Necrosis and Renal Failure

1971 · Thomas D. Boyer · JAMA · 202

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

2008 · Marlyn J. Mayo, Julie Parkes, et al. · Hepatology · 201

Constitutional telomerase mutations are genetic risk factors for cirrhosis

2011 · Rodrigo T. Calado, Jennifer Brudno, et al. · Hepatology · 188

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

2020 · Florence Wong, Salvatore Piano, et al. · Journal of Hepatology · 172

American Association for the Study of Liver Diseases Practice Guidelines: The Role of Transjugular Intrahepatic Portosystemic Shunt Creation in the Management of Portal Hypertension

2005 · Thomas D. Boyer, Ziv J. Haskal · Journal of Vascular and Interventional Radiology · 171

Zakim and Boyer's Hepatology: A Textbook of Liver Disease

2016 · Thomas D. Boyer, Michael P. Manns, et al. · 169

Transjugular intrahepatic portosystemic shunt: current status1 1Abbreviation used in this paper: TIPS, transjugular intrahepatic portosystemic shunt.

2003 · Thomas D. Boyer · Gastroenterology · 161

Hepatic Hydrothorax

1997 · Robert Strauss, Thomas Boyer · Seminars in Liver Disease · 158

Works count: 191

Citation count: 11,500

H-index: 51

I10-index: 101